BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12964942)

  • 1. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.
    Anzick SL; Azorsa DO; Simons SS; Meltzer PS
    BMC Cancer; 2003 Sep; 3():22. PubMed ID: 12964942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
    Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
    Azorsa DO; Cunliffe HE; Meltzer PS
    Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
    Reiter R; Oh AS; Wellstein A; Riegel AT
    Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.
    Oh A; List HJ; Reiter R; Mani A; Zhang Y; Gehan E; Wellstein A; Riegel AT
    Cancer Res; 2004 Nov; 64(22):8299-308. PubMed ID: 15548698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
    Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
    Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
    Anzick SL; Kononen J; Walker RL; Azorsa DO; Tanner MM; Guan XY; Sauter G; Kallioniemi OP; Trent JM; Meltzer PS
    Science; 1997 Aug; 277(5328):965-8. PubMed ID: 9252329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of AIB1 expression in human breast cancer.
    Iwase H; Omoto Y; Toyama T; Yamashita H; Hara Y; Sugiura H; Zhang Z
    Breast Cancer Res Treat; 2003 Aug; 80(3):339-45. PubMed ID: 14503806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
    Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
    Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.
    Bouras T; Southey MC; Venter DJ
    Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
    Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
    Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
    Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
    Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
    Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
    Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cell Phenotypes in ER
    Truong TH; Hu H; Temiz NA; Hagen KM; Girard BJ; Brady NJ; Schwertfeger KL; Lange CA; Ostrander JH
    Mol Cancer Res; 2018 Apr; 16(4):707-719. PubMed ID: 29348189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.